C. Truffot-Pernot
Impact in
- Infectious Diseases top 0.2%
- Tuberculosis Research and Epidemiology
- Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria
Papers in
-
- Tuberculosis Research and Epidemiology 72
- Epidemiology 61
- Mycobacterium research and diagnosis 57
- Pneumocystis jirovecii pneumonia detection and treatment 8
- Co-authors
- J Grosset (45 shared papers)Vincent Jarlier (33 shared papers)Nacer Lounis (21 shared papers)Emmanuelle Cambau (11 shared papers)Nicolas Véziris (15 shared papers)Koen Andries (5 shared papers)Wladimir Sougakoff (17 shared papers)Botao Ji (9 shared papers)
- Journals
- Antimicrobial Agents and Chemotherapy (29 papers)Journal of Clinical Microbiology (5 papers)American Journal of Respiratory and Critical Care Medicine (5 papers)Infection Control and Hospital Epidemiology (2 papers)The Lancet (2 papers)
- Partner nations
- FranceUnited StatesMorocco
In The Last Decade
C. Truffot-Pernot
94 papers receiving 4.9k citations
C. Truffot-Pernot's Hit Papers
Peers
Comparison fields: 5 of 109
- Infectious Diseases 3.7k
- Molecular Medicine 565
- Epidemiology 2.9k
- Small Animals 220
- Microbiology 21
Countries citing papers authored by C. Truffot-Pernot
This map shows the geographic impact of C. Truffot-Pernot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Truffot-Pernot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Truffot-Pernot more than expected).
Fields of papers citing papers by C. Truffot-Pernot
This network shows the impact of papers produced by C. Truffot-Pernot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Truffot-Pernot. The network helps show where C. Truffot-Pernot may publish in the future.
Co-authors
The 25 scholars most cited alongside C. Truffot-Pernot, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 97 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium tuberculosis Hit paper breakdown → | 2004 | 1656 |
| 2 | 1994 | 216 | |
| 3 | 2005 | 155 | |
| 4 | 1998 | 151 | |
| 5 | 2006 | 132 | |
| 6 | 1992 | 121 | |
| 7 | 1989 | 119 | |
| 8 | 1995 | 116 | |
| 9 | 2001 | 109 | |
| 10 | 2006 | 100 | |
| 11 | 2006 | 99 | |
| 12 | 1997 | 96 | |
| 13 | 1993 | 91 | |
| 14 | 2000 | 89 | |
| 15 | 1999 | 83 | |
| 16 | 1990 | 74 | |
| 17 | 1994 | 74 | |
| 18 | 2010 | 72 | |
| 19 | 1993 | 72 | |
| 20 | 1991 | 69 |
About C. Truffot-Pernot
C. Truffot-Pernot is a scholar working on Infectious Diseases, Epidemiology, Molecular Biology, Surgery and Molecular Medicine, having authored 97 papers that have together received 5.1k indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (72 papers), Mycobacterium research and diagnosis (57 papers), Cancer therapeutics and mechanisms (23 papers), Phenothiazines and Benzothiazines Synthesis and Activities (11 papers), Infectious Diseases and Tuberculosis (11 papers), Antibiotic Resistance in Bacteria (9 papers), Antibiotics Pharmacokinetics and Efficacy (8 papers) and Pneumocystis jirovecii pneumonia detection and treatment (8 papers). The work is most often cited by research in Infectious Diseases (3.7k citations), Molecular Medicine (565 citations), Epidemiology (2.9k citations), Small Animals (220 citations) and Microbiology (21 citations). C. Truffot-Pernot has collaborated with scholars based in France, United States and Morocco. Frequent co-authors include J Grosset, Vincent Jarlier, Nacer Lounis, Emmanuelle Cambau, Nicolas Véziris, Koen Andries, Wladimir Sougakoff, Botao Ji, Philip Timmerman and Peter Williams. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Journal of Clinical Microbiology, American Journal of Respiratory and Critical Care Medicine, Infection Control and Hospital Epidemiology and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.